Insulet Seeks $30M In Atty Fees, Costs After Trade Secret Win
By Andrea Keckley
After winning a nearly $60 million judgment in a trade secrets lawsuit against South Korean company EOFlow Co. Ltd., medical device company Insulet Corp. has told a Massachusetts federal judge that it should be granted a little over $30 million in attorney fees and litigation costs in light of the rival's "remarkable" misappropriation of its technology for a wearable insulin patch pump.
Memorandum attached |
Read full article »
| Save to favorites »
CASES
LAW FIRMS
EXPERT ANALYSIS
|